Ron Cobb, PhD, is an accomplished molecular biologist with over 30 years of biopharmaceutical and medical device research and development experience. He has a proven track record, developing multiple therapeutic modalities, including monoclonal antibodies, therapeutic proteins, lives attenuated bacterial, and viral vaccines, as well as gene and cell therapy products from early-stage research through phase I and II 2 clinical development.
Prior to his role at Amplify, he was chief scientific officer at Ology Bioservices, Inc. Previously, he was director of research and development at RTI Surgical, Inc., leading a team that launched over 20 new products. In his career, he has worked in several therapeutic and medical device areas, including immunology, cardiovascular, infectious disease, and, most recently, gene therapy. Ron received his BA in biology from Wake Forest University in Winston-Salem, NC. He earned his PhD in biochemistry from the Medical College of Georgia in Augusta, GA.